Intestinal microbiota and vaccine efficacy in children from resource poor settings - potential impact for the usefulness of probiotics?

Hajela, N; Chattopadhyay, S; Nair, G B; Ganguly, N K

Hajela, N; Chattopadhyay, S; Nair, G B; Ganguly, N K.

Affiliation

Hajela N; Gut Microbiota and Probiotic Science Foundation (India), M-4, Level one, South Extension Part - Ii, New Delhi 110049, India.
Chattopadhyay S; Rajiv Gandhi Centre for Biotechnology, Thycaud Post, Poojappura, Thiruvananthapuram, Trivandrum, 695014 Kerala, India.
Nair GB; Rajiv Gandhi Centre for Biotechnology, Thycaud Post, Poojappura, Thiruvananthapuram, Trivandrum, 695014 Kerala, India.
Ganguly NK; Institute of Liver and Biliary Science, New Delhi, India.

Benef Microbes ; 11(4): 319-328, 2020 Aug 12.

Article in En | MEDLINE | ID: mdl-32720834

Subject(s)

Developing Countries; Gastrointestinal Microbiome/immunology; Probiotics; Vaccines/immunology; Animals; Child; Humans; Immunogenicity, Vaccine; Immunomodulation; Probiotics/administration & dosage; Probiotics/pharmacology; Vaccination; Vaccines/administration & dosage

Key words

developing countries; probiotics; vaccine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Probiotics / Developing Countries / Gastrointestinal Microbiome Aspects: Determinantes_sociais_saude Limits: Animals / Child / Humans Language: En Journal: Benef Microbes Year: 2020 Document type: Article Affiliation country: India Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google